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Abstract Myosin regulatory light chain interacting protein
(MIR) belongs to the ezrin, radixin, moesin (ERM) family of
proteins involved in membrane cytoskeleton interactions and cell
dynamics. MIR contains, beside the ERM domain, a RING zinc
¢nger region. Immunocytochemistry showed that full-length
MIR and the subdomains localize di¡erently in cells. Cell frac-
tionation revealed a similar distribution of full-length MIR and
the RING domain protein in the Triton X-100-insoluble frac-
tion. The neurite outgrowth inhibitory activity of MIR was
attributed to the RING domain. MIR levels were controlled in
the cells depending on the intact RING domain and proteasome
activity. The dynamic regulation of MIR contributes to its ef-
fects on neurite outgrowth and cell motility.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The ERM proteins, ezrin, radixin and moesin, link the actin
cytoskeleton to membrane-bound proteins located at di¡erent
membrane sites, i.e. microvilli, membrane ru¥es and cell^cell
contact points [1^3]. These proteins have an actin binding site
in the C-terminal part, and a FERM domain in the NH-ter-
minal part. The FERM domain has been found in di¡erent
proteins and is thought to be mediate protein^protein and
protein^membrane interactions [4]. The FERM proteins can
in£uence cell adhesion and signal transduction events through
phosphorylation and interaction with phosphoinositides and
the Rho family of proteins [1^3]. The ERM subgroup of pro-
teins is known to interact with other proteins, such as CD44
and ICAM-1, -2 and -3, which helps in establishing membrane
specializations [5]. In keeping with their known functions in
controlling membrane^cytoskeleton interactions, the ERM
proteins are usually localized close to the cell membrane.
However, the exact mechanisms by which the ERM proteins
mediate cellular interactions and in£uence cell motility are not
fully understood.
We have recently described a novel ERM family protein,
myosin regulatory light chain interacting protein (MIR),
which has an ERM domain at the N-terminus but which lacks
an actin binding site. In contrast, MIR has a RING zinc
¢nger domain in the C-terminal region [6]. Studying PC12
cells, we observed that MIR inhibited neurite outgrowth in-
duced by nerve growth factor. This e¡ect was ascribed to the
interaction of MIR with the myosin regulatory light chain
(MRLC). To learn more about the mechanism underlying
the action of MIR, we studied here which part of MIR, the
ERM or the RING domain, is mainly involved in neurite
outgrowth. We also determined the distribution of the full-
length MIR and C- or N-terminally truncated MIR proteins
in cells, and compared them with that for the ERM protein
moesin. The results show that the neurite outgrowth inhibi-
tory activity of MIR resides in the RING domain. The RING
domain and the full-length MIR were mainly codistributed in
the Triton X-100-insoluble fraction, whereas the ERM do-
main was also found in the soluble fraction. The ERM and
RING domains were also di¡erentially localized in cells and
apart from moesin. The levels of MIR were downregulated in
cells in a process depending on the activity of the proteasome
and an intact RING domain, which exhibited ubiquitination
activity.
2. Materials and methods
2.1. Plasmids
pEGFP-ERM (encoding aa 1^295 of MIR), pEGFP-RING (encod-
ing aa 296^445 of MIR) and pEGFP-MIR C387A were generated
from pEGFP-MIR [6] by polymerase chain reaction and con¢rmed
by sequencing analysis. pEGFP was used as control.
2.2. Transfection, neurite outgrowth and solubility assay
Neuroblastoma N2-A cells were transfected with the following plas-
mids using Fugene (Roche): green £uorescent protein (GFP), GFP-
ERM, GFP-RING and GFP-MIR. After 40 h, the number of cells
bearing neurites longer than twice the cell diameter was scored. In
each experiments more than 100 cells were counted, and data are
expressed as meanGS.E.M. For statistical analyses Student’s t-test
was used.
For solubility assays, COS-7 cells were transfected with the di¡erent
plasmids. After 40 h the plates were washed once with phosphate-
bu¡ered saline (PBS). Cells were scraped into lysis bu¡er (50 mM
Tris^HCl, pH 7.5, 100 mM NaCl, 3 mM EGTA, 0.5% Triton X-
100 and protease inhibitors (Roche)), and kept for 5 min on ice. 30
Wl were saved, mixed with 10 Wl 4Usodium dodecyl sulfate (SDS)
loading bu¡er and sonicated (total cell lysate). The remaining cell
lysate was centrifuged at 13 000Ug for 10 min, and the supernatant
was mixed with 4USDS loading bu¡er (soluble fraction); the pellet
was dissolved in 1USDS loading bu¡er and sonicated (insoluble frac-
tion). Equal amounts were then analyzed on 10% SDS^polyacryl-
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amide gel electrophoresis (PAGE) and subsequent Western blotting
using a monoclonal anti-GFP antibody (Roche) and horseradish per-
oxidase-coupled anti-mouse secondary antibodies (Jackson).
2.3. Ubiquitination assay
N2-A cells were transfected with expression vectors for His-tagged
ubiquitin [7] and either GFP, GFP-MIR, GFP-ERM, GFP-RING or
MIR mutated in the RING domain (Cys387Ala). The mutation of the
cysteine residues has been shown to abolish the ubiquitin ligase activ-
ity of proteins containing RING zinc ¢ngers [8]. After 24 h, 10 WM
MG132 in serum-free medium was added for 6 h and cells were lysed
in ice-cold RIPA bu¡er (50 mM Tris^HCl, pH 8.0, 150 mM NaCl,
1% Triton X-100, 0.5% Na-deoxycholate, 0.1% SDS and protease
inhibitors). Immunoprecipitation was carried out with polyclonal
anti-GFP antibodies (1:250, Clontech) and protein G-Sepharose.
The beads were washed three times, and the pellet was boiled in
1USDS^PAGE bu¡er. Cell lysates and immunoprecipitates were an-
alyzed by SDS^PAGE followed by Western blotting using anti-GFP
(1:1000, Roche) or anti-ubiquitin antibodies (1:1000, A⁄nity Re-
search).
2.4. Immunocytochemistry
COS-7 cells were seeded on coverslips and transfected using Fu-
gene. Sixteen hours after transfection the cells were washed with
PBS, ¢xed in 4% paraformaldehyde and permeabilized in PBS/5%
normal goat serum/0.05% Triton X-100. The cells were stained with
anti-moesin antibodies (1:200, Upstate) and Cy3-tagged goat anti-
rabbit secondary antibodies (Jackson). Signals were visualized with
a Zeiss Axiophot microscope and analyzed with deconvolution soft-
ware (Zeiss). 3. Results and discussion
3.1. Activities of di¡erent MIR constructs in the control of
neurite outgrowth
We have recently identi¢ed MIR, a novel member of the
ERM protein family, as a potent inhibitor of neurite out-
growth expressed in brain [6,9]. In order to reveal which
part of MIR is responsible for this inhibition, we generated
deletion constructs fused to GFP and tested them in an assay
for neurite outgrowth together with the full-length protein
and GFP serving as control (Fig. 1). In accordance with ear-
lier results, full-length MIR inhibits neurite outgrowth dra-
matically compared to the GFP control. The RING domain
also exhibits neurite outgrowth inhibition, although somewhat
attenuated compared to MIR. The di¡erence between MIR
and the RING domain only was not statistically signi¢cant
(Ps 0.1, n=300). In contrast, the ERM domain did not de-
crease neurite outgrowth (Fig. 1). There was a slight increase
in the number of cells bearing neurites expressing the ERM
domain, but the di¡erence was not statistically signi¢cant
(Ps 0.1, n=300). Thus, the neurite outgrowth inhibitory ac-
tivity in MIR is associated with the RING domain, whereas
the ERM domain does not signi¢cantly contribute to this
e¡ect.
3.2. Subcellular fractionation of di¡erent MIR constructs
To study whether the di¡erent properties of the subdomains
in MIR are related to their di¡erent localization in cells, we
transfected COS-7 cells with the di¡erent constructs and an-
alyzed the solubility of the proteins expressed. Fig. 2 shows
that a large proportion of full-length MIR resides in the Tri-
ton-insoluble fraction, whereas only little protein was detected
in the soluble fraction. This result was paralleled by the
RING domain, which remained in the insoluble fraction
with almost no protein in the soluble part. In contrast, the
ERM domain of MIR was recovered about equally in the
Triton-soluble and in the insoluble fractions (Fig. 2). These
data correspond to those observed for the ERM protein ezrin.
Fig. 1. Di¡erent MIR constructs and their e¡ects on neurite out-
growth. A: The following MIR constructs were used in the present
study. The numbers indicate the amino acid position in the protein.
C387A shows mutated MIR protein with the cysteine residue re-
placed with alanine. B: N2-A neuroblastoma cells were transfected
with the di¡erent constructs. Cells were incubated without serum
for 16 h and the number of cells bearing neurites was determined.
Experiments were done in triplicate, and the values represent
meanGS.E.M. ***P9 0.01 for control vs. the RING construct, n.s.
not signi¢cant for control vs. the ERM construct.
Fig. 2. Subcellular distribution of di¡erent full-length and truncated
MIR proteins. COS-7 cells were transfected with the MIR con-
structs and subcellular compartments obtained as described in Sec-
tion 2. Proteins were analyzed by Western blotting using an anti-
GFP antibody.
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Ezrin has a readily soluble N-terminus, i.e. the ERM domain,
and a rather insoluble C-terminal part [10].
3.3. Subcellular localization of MIR constructs
To study the subcellular localization of the di¡erent sub-
domains of MIR cells in more detail, we performed immuno-
cytochemical stainings of COS-7 cells after transfection of the
constructs (Fig. 3). The data showed that full-length MIR and
the ERM domain exhibited a similar distribution in the cells,
with a punctuated staining pattern in the cells (Fig. 3d,g). The
RING domain on the other hand was accumulated in subcel-
lular structures in the cytoplasm (Fig. 3j). These resembled
aggregates observed previously with other RING ¢nger-con-
taining proteins, such as the X-linked inhibitory of apoptosis
protein (XIAP). In XIAP the occurrence of such intracellular
aggregates of the protein was associated with proteasome ac-
tivity and the presence of the RING domain [10]. To study
whether the distribution of the RING domain in MIR is
linked to its possible activity as ubiquitin ligase in cells, we
set out to mutate one of the cysteine residues. These residues
have been shown to be required for the intact function of the
RING domain in di¡erent RING zinc ¢nger-containing pro-
teins [8]. The novel MIR construct, harboring a mutation in
cysteine residue 387, C387A, in the RING domain (Fig. 1A),
was then transfected into COS-7 cells. The results showed that
the C387A mutant MIR protein showed a largely similar dis-
Fig. 3. Cellular localization of full-length and truncated MIR proteins. COS-7 cells were transfected and visualized using the following con-
structs: GFP (a^c), GFP-MIR (d^f), GFP-ERM (g^i), GFP-RING (j^l) and GFP-MIRC387A (m^o). Left panel, GFP £uorescence. Middle
panel, an anti-moesin antibody was used for staining. Right panel, merged images of GFP £uorescence and moesin staining. Scale bar, 15 Wm.
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tribution to that of wild-type MIR (Fig. 3m), and di¡erent
from the protein construct with intact RING domain only.
To further characterize the localization of the di¡erent MIR
constructs, the cells were also stained for the ERM protein
moesin. The results showed that moesin was distributed in a
rather similar pattern to those of the ERM-containing and
full-length MIR proteins (Fig. 3). This was also observed
for the C387A mutant MIR protein (Fig. 3). However, the
protein bearing an intact RING domain was not localized
with moesin nor with any other of the proteins expressed
(Fig. 3). To study whether moesin localizes in the same com-
partment as MIR, we analyzed the cells using the deconvolu-
tion method for protein detection. The results showed that
there was no exact colocalization of moesin and of MIR
and its subdomains in cells. The same result applied to double
stainings using an anti-ezrin antibody (data not shown). This
probably re£ects the partly di¡erent functions of the two
ERM proteins and MIR, with moesin and ezrin being in-
volved in protein^protein interactions di¡erent from those
of MIR.
Taken together the data show that the ERM domain alone
is distributed in a similar fashion to that of full-length MIR in
cells. In contrast, the RING domain was present in distinct
subcellular structures in a dotlike fashion. The biochemical
analyses for solubility, however, showed that full-length
MIR is mainly insoluble similar to the RING domain, where-
as the ERM domain is rather soluble. The results of these two
types of studies are not necessarily in con£ict and they re£ect
di¡erent aspects and behavior of the same protein and its
subdomains. The results can be interpreted to indicate that
the ERM domain in MIR mediates higher solubility of the
protein, whereas the RING domain is involved in protein^
protein interactions with a change in the cellular localization
of the protein.
3.4. The RING domain in MIR mediates ubiquitination
The analysis of the expression of the di¡erent constructs
revealed that the levels of the MIR and the RING domain
proteins were downregulated in cells (Fig. 4A). In contrast the
protein bearing the ERM domain was rather stable in the cells
(Fig. 4A). Addition of the proteasome inhibitor MG132, how-
ever, blocked the observed decline in MIR and RING domain
proteins. This indicates that MIR and the RING domain
proteins are controlled by the activity of the proteasome
and can be downregulated probably by ubiquitination.
In keeping with this we observed that the C387A mutant
of MIR lacking the intact functional RING domain was
stable in the cells (Fig. 4A). The C387A mutant protein
was also equally expressed in the absence and presence of
MG132.
To study the role of ubiquitination in the function of the
RING construct, we performed a ubiquitination assay for the
protein. The results showed that under the conditions of pro-
tein decline, the construct containing the RING domain was
readily ubiquitinated, as shown by the presence of ubiquitin
chains in the protein (Fig. 4B). This process was dependent on
the Cys387 residue in the RING domain as evident by data
showing no ubiquitination using the mutant protein (Fig. 4B).
These results show that the RING domain is ubiquitinated
and downregulated by the proteasome. Similar data were
also observed for the full-length MIR although the presence
of ubiquitin chains was harder to detect due to the high mo-
lecular weight of the fusion EGFP-MIR protein (data not
shown).
3.5. Functional considerations regarding the MIR subdomains
Taken together we have shown that the two major protein
motifs in MIR, the ERM and the RING ¢nger domain, ex-
hibited a di¡erential functional activity in regulating neurite
outgrowth in N2-A cells. The known neurite outgrowth inhib-
iting activity of MIR was associated with the function of the
RING domain but not with that of the ERM region. The two
truncated forms of MIR were also distributed in di¡erent
compartments, as shown by cell fractionation and localization
of the GFP fusion proteins in COS-7 cells. The ERM domain
was almost evenly distributed within the cell, whilst the RING
¢nger domain was found in the particular fraction. In keeping
with these results, the ERM domain was soluble, whereas the
RING domain was recovered in the Triton X-100-insoluble
fraction, as shown also for full-length MIR. Functionally, the
protein bearing the RING domain was found to be down-
regulated in cells, which could be attenuated by the presence
of the proteasome inhibitor MG132. This was also observed
Fig. 4. Expression of full-length and truncated MIR proteins and
their regulation by proteasome activity. A: N2-A cells were trans-
fected with the di¡erent MIR constructs and incubated in the ab-
sence or presence of 10 WM MG132 to inhibit proteasomes. Proteins
were detected by Western blotting using anti-GFP antibodies. Note
the downregulation of full-length MIR and RING-containing pro-
teins, which was inhibited by MG132. B: Transfected N2-A cells
were incubated in the presence of 10 WM MG132. Immunoprecipita-
tion was carried out using anti-GFP antibodies and protein G-Se-
pharose. Immunoprecipitates were analyzed by Western blotting
with anti-ubiquitin antibodies to reveal ubiquitinated proteins. Note
the ubiquitination of intact RING-containing protein but not of the
C387A mutant.
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with the full-length MIR protein but not with the ERM do-
main nor with the C387A mutant protein, lacking ubiquitin
ligase activity.
In this study we show that the expression of MIR can lead
to its own degradation. We recently observed that MIR can
also ubiquitinate the binding partner MRLC with e¡ects on
neurite outgrowth [11]. The present study shows that the ubiq-
uitin ligase activity of the RING can also be directed towards
the protein itself indicating that the degradation of MIR can
be regulated by autoubiquitination. A similar dual mode of
regulation has also been described for other RING ¢nger-
containing proteins such as the inhibitor of apoptosis proteins
[12,13]. In this respect, XIAP was found to be able to ubiq-
uitinate itself and also other substrates such as caspase-3
[13,14]. However, it is not fully understood how these two
processes are interconnected in RING ¢nger-containing pro-
teins, and whether the di¡erent substrates can compete with
each other for ubiquitination. We are currently studying
which other proteins can be ubiquitinated by the RING do-
main in MIR, and whether these interactions a¡ect the dy-
namics and function of MIR in the regulation of cell motility.
The present results indicate a dynamic regulation of the levels
and activity of MIR, which has a bearing on its cellular func-
tions in neurite outgrowth and cell motility.
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